Viseven

AUGUST 29, 2024

As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. 5G represents the 5th generation of cellular technology and is the gold standard in wireless communication today. In this article, we will explore these opportunities.

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 19, 2022

This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. by the end of 2023 and may continue to rise in 2024 to 5%. Companies relying on angel investors and venture capitalists will be most affected by an economic downturn.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Generic Medicine 69

Pharmaceutical Technology

FEBRUARY 17, 2023

However, Amgen and other pharmaceutical companies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov.

Dosage 115

Dosage Clinical Pharmacology Pharmaceutical Companies Pharmaceutical Companies 115

PharmaState Academy

JANUARY 23, 2024

He discussed the role of culture in brand building, the importance of clear communication, and storytelling by the brand manager to motivate the sales team. Mr. Sankar highlighted the importance of consistency and focus in pharmaceutical marketing and the role of pricing in brand perception.

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Free Report.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

PharmaState Academy

MARCH 19, 2024

“We are delighted with the overwhelming response and engagement at the Pharma Industry Townhall 2024 that saw 150 plus Pharma enthusiasts joining the event,” said Dr. Satish Gupta, COO at PharmaState Academy. Understanding UCPMP 2024 has become the need of the hour for the Pharma Industry professionals.

Communication 40

Communication Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles. Free Report.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

Pharmaceutical Technology

MAY 5, 2023

To keep within this limit, pharmaceutical companies have had to pay rebates on their sales back to the NHS on all expenditures above the capped limit. Companies that choose not to take part in the voluntary scheme must partake in a statutory scheme. The revised voluntary scheme has an expected launch on January 1, 2024.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

APRIL 19, 2022

I think the most important thing is making a good team and also good communication within that team is very important. Next in the pipeline, is a non-opioid treatment for chronic pain looking to complete pre-clinical studies by 2024. Everyone in our team is very valuable,” he said. “I Moving to the global stage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

JUNE 15, 2023

Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. By the end of the year, the company will seek to identify similar issues in European biosimilars, followed by the Middle East and Africa in Q1 2024, and Asia Pacific in Q2.

Biosimilars 52

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

DECEMBER 24, 2024

The impact of packaging is felt only when it does not do its job and therefore pharmaceutical companies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. per cent CAGR.

Packaging 105

Packaging Labelling Pharmaceutical Companies Pharmaceutical Companies 105

GMPSOP

MARCH 20, 2024

Instrument calibration procedure for pharmaceutical industry Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Last Updated on March 20, 2024 Prev PREVIOUS POST Have you ever wondered if the scales at the grocery checkout show the right amount? </p>

Documentation 52

Documentation Pharmaceutical Manufacturing Labelling Communication 52

Viseven

JANUARY 15, 2025

In 2024 , the top 20 pharmaceutical companies have already announced that they are actively researching uses for AI in R&D. Life sciences companies can use AI to analyze vast amounts of data and identify drug targets, design small molecules, generate synthesis pathways for chemical compounds, and predict drug properties.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding Communication 52

Drug Patent Watch

DECEMBER 11, 2024

This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Pharmaceutical companies should look for CDMOs with a proven track record of working with various molecules and pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 98